|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2022―Sep―28 |
Drug genetic associations with COVID-19 manifestations: a data mining and network biology approach |
Theodosia Charitou, Panagiota I. Kontou, Ioannis A. Tamposis, Georgios A. Pavlopoulos, Georgia G. Braliou, Pantelis G. Bagos |
2 |
[GO] |
2021―Jul―23 |
G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19 |
Jorge E. B. da Rocha, Houcemeddine Othman, Caroline T. Tiemessen, Gerrit Botha, Michèle Ramsay, Collen Masimirembwa, Clement Adebamowo, Ananyo Choudhury, Jean-Tristan Brandenburg, Mogomotsi Matshaba, Gustave Simo, Francisco-Javier Gamo, Scott Hazelhurst, Jorge E. B. da Rocha |
3 |
[GO] |
2021―Feb―04 |
Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs |
Osama A. Badary |
4 |
[GO] |
2020―Dec―15 |
Does the RAAS play a role in loss of taste and smell during COVID-19 infections? |
Heloise R. Luchiari, Ricardo J. Giordano, Richard L. Sidman, Renata Pasqualini, Wadih Arap |
|